Abstract:As pharmaceutical excipients, mesoporous silica nanoparticles (MSNs) have attracted considerable concern based on potential risks to the public. The impact of MSNs on biochemical metabolism is poorly understood, and few studies have compared the effects of MSNs administered via different routes. To evaluate the hepatotoxicity of MSNs, metabolomics, proteomics and transcriptomic analyses were performed in mice after intravenous (20 mg/kg/d) or oral ad-ministration (200 mg/kg/d) of MSNs for 10 days. Intravenous injection induced significant hepatic injury based on pathological inspection and increased the levels of AST/ALT and the inflammatory factors IL-6, IL-1β and TNF-a. Omics data suggested intravenous administration of MSNs perturbed the following metabolites: succinate, hypoxanthine, GSSG, NADP+, NADPH and 6-phosphogluconic acid. In addition, increases in GPX, SOD3, G6PD, HK, and PFK at proteomic and transcriptomic levels suggested elevation of glycolysis and pentose phosphate pathway, synthesis of glutathione and nucleotides, and antioxidative pathway activity, whereas oxidative phosphorylation, TCA and mitochondrial energy metabolism were reduced. On the other hand, oral administration of MSNs disturbed inflammatory factors and metabolites of ribose-5-phosphate, 6-phosphogluconate, GSSG, and NADP+ associated with the pentose phosphate pathway, glutathione synthesis and oxidative stress albeit to a lesser extent than intravenous injection despite the administration of a ten-fold greater dose. Overall, systematic biological data suggested that intravenous injection of nanoparticles of pharmaceutical excipients substantially affected hepatic metabolism function and induced oxidative stress and inflammation, whereas oral administration exhibited milder effects compared with intravenous injection.

Metabolic Fate and Subchronic Biological Effects of Core-Shell Structured Fe3O4@SiO2-NH2 Nanoparticles

Silica nanoparticles: Biomedical applications and toxicity

Biodistribution and toxicity of intravenously administered silica nanoparticles in mice

Proteomics revealed composition- and size-related regulators for hepatic impairments induced by silica nanoparticles

Integrative Metabolomics, Proteomics and Transcriptomics Analysis Reveals Liver Toxicity of Mesoporous Silica Nanoparticles

Risk Assessment of Silica Nanoparticles on Liver Injury in Metabolic Syndrome Mice Induced by Fructose.

The effects of size and surface modification of amorphous silica particles on biodistribution and liver metabolism in mice.

Long-term Effects of Nanoparticles on Nutrition and Metabolism.

Preparation of SiO2-Protecting Metallic Fe Nanoparticle/SiO2 Composite Spheres for Biomedical Application

The Internalization Pathway, Metabolic Fate and Biological Effect of Superparamagnetic Iron Oxide Nanoparticles in the Macrophage-Like RAW264.7 Cell

Adverse effects and underlying mechanism of amorphous silica nanoparticles in liver

Neurotoxicity of Silica Nanoparticles: Brain Localization and Dopaminergic Neurons Damage Pathways

Particokinetics and Extrapulmonary Translocation of Intratracheally Instilled Ferric Oxide Nanoparticles in Rats and the Potential Health Risk Assessment.

In Vivo Biodistribution and Synergistic Toxicity of Silica Nanoparticles and Cadmium Chloride in Mice.

Integrated Metabonomics Analysis of the Size-Response Relationship of Silica Nanoparticles-Induced Toxicity in Mice

Nanosafety evaluation through feces: A comparison between selenium nanoparticles and selenite in rats

Adverse effects of amorphous silica nanoparticles: Focus on human cardiovascular health

Uptake, Biological Fate, and Toxicity of Metal Oxide Nanoparticles

Tissular localization and excretion of intravenously administered silica nanoparticles of different sizes

State of the Art of Silica Nanoparticles: An Overview on Biodistribution and Preclinical Toxicity Studies

Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery